Answers are grounded in this paper and cite their sources.
Shows enhanced enantioselectivity in engineered enzymes, indicating potential for drug synthesis.
Using 4-phenylbutan-2-one as the model substrate, an (R)-enantiospecific AmDH (M0) derived from l-amino acid dehydrogenase was converted into (S)-enantioselective enzymes (M4–M7) through several rounds of semirational iterative mutations. Variants M6-1 and M7 were successfully applied to synthesize (S)-amines (70–81% yields) and (R)-β-amino alcohols (60–65% yields) with 95% to >99% ee. Molecular dynamics simulations provided insights into the role of mutations in substrate recognition and stereoselective control, offering important guidance for regulating the stereoselectivity of AmDHs through protein engineering.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: